SPECTRAL MOLECULAR IMAGING, INC.

Medtech · Acquired

SkinSpect: a multimode dermoscopic imaging device combining hyperspectral, polarization, and fluorescence imaging for non-invasive melanoma diagnosis

opmol.com →
Grants
$2.8M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$150K
1 award · Defense
#482 of 4531 in medtech
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Hyperspectral Imaging-Based Multimode Dermoscope For Early Melanoma Detection$1,360,886
Federal contractDepartment of Defense · Igf::ot::igf Broad Spectrum Optical Property Characterization STTR I$149,998
Federal grantDepartment of Health and Human Services · Phase II · Hyperspectral Imaging-Based Multimode Dermoscope For Early Melanoma Detection$671,810
Federal grantDepartment of Defense · Phase II · Broad Spectrum Optical Property Characterization$746,438
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
479Glaukos Corporation$160K$76M
480Elucid Bioimaging Inc.$151K$116M
481ENDECTRA LLC$150K—
482SPECTRAL MOLECULAR IMAGING, INC.$150K—
483MICROHORTONE LLC$150K—
484INFUSENSE LLC$150K$2.0M
485CELL PRESERVATION SERVICES INC$150K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 3
  • Method And System For Characterizing Tissue In Three Dimensions Using Multimode Optical Measurementsapplication
  • Disposable Calibration End-cap For Use In A Dermoscope And Other Optical Instrumentsapplication
  • Disposable Calibration End-Cap for Use in a Dermoscope and Other Optical Instrumentsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.